The treatment of spastic equinovarus foot after stroke

Critical Reviews in Physical and Rehabilitation Medicine

Volumn 19, Issue 3, 2007, Pages 195-211

  Deltombe, Thierry ^a   Gustin, Thierry ^a   De Cloedt, Philippe ^a   Vandemeulebroecke, Maryse ^a   Hanson, Philippe ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Botulinum toxin; Foot; Muscle spasticity; Nerve block; Neurotomy; Stroke

Indexed keywords

ALCOHOL; BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; DANTROLENE; DIAZEPAM; PHENOL; SPASMOLYTIC AGENT; TIZANIDINE;

ANESTHESIA; ARTHRODESIS; CATHETER COMPLICATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSTIPATION; DROWSINESS; DRUG EFFICACY; DYSESTHESIA; EDEMA; ELECTROMYOGRAPHY; FEEDBACK SYSTEM; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL ELECTRICAL STIMULATION; FUNCTIONAL INDEPENDENCE MEASURE; GAIT; HEADACHE; HUMAN; HYPOTENSION; INJECTION SITE PAIN; KINEMATICS; LIQUORRHEA; MENINGITIS; MUSCLE WEAKNESS; NERVE BLOCK; NEURECTOMY; NEUROLYSIS; NEUROSURGERY; ORTHOPEDIC SURGERY; ORTHOSIS; PAIN; PERIPHERAL EDEMA; PES EQUINOVARUS; PHLEBITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEDATION; SEIZURE; SENSORY DYSFUNCTION; SIDE EFFECT; SPASTIC EQUINOVARUS FOOT; SPASTICITY; STROKE; TENDON SURGERY; TENDON TRANSFER; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; URINE RETENTION; WEAKNESS; WITHDRAWAL SYNDROME; WORLD HEALTH ORGANIZATION; WOUND COMPLICATION;

EID: 37349119085     PISSN: 08962960     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevPhysRehabilMed.v19.i3.20     Document Type: Review

References (117)

1. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Recovery of walking function in stroke patients: the Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995;76:27-32.
2. Barnes MP. An overview of the clinical management of spasticity. In: Barnes MP, Johnson GR, editors. Upper motor neuron syndrome and spasticity: clinical management and neurophysiology. Cambridge (UK): Cambridge University Press; 2001. p. 1-11.
3. Verdie C, Daviet JC, Borie MJ, Popielarz S, Munoz M, Salle JY, Rebeyrotte I, Dudognon P. Epidemiology of pes varus and/or equinus one year after a first cerebral hemisphere stroke: a propos of a cohort of 86 patients. Ann Readapt Med Phys. 2004;47(2):81-6.
4. Burridge JH, Wood DE, Taylor PN, McLellan DL. Indices to describe different muscle activation patterns, identified during treadmill walking, in people withspastic drop-foot. Med Eng Phys. 2001;23(6):427-34.
5. Fuller DA, Keenan MA, Esquenazi A, Whyte J, Mayer NH, Fidler-Sheppard R. The impact of instrumented gait analysis on surgical planning: treatment of spastic equinovarus deformity of the foot and ankle. Foot Ankle Int. 2002;23(8):738-43.
6. Gracies JM. Pathophysiology of spastic paresis. II: emergence of muscle overactivity. Muscle Nerve. 2005;31:552-71.
7. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disorder of motor control. Chicago: Year Book Medical Publishers; 1980. p. 485-94.
8. Keenan MA, Gorai AP, Smith CW, Garland DE. Intrinsic toe flexion deformity following correction of spastic equinovarus deformity in adults. Foot Ankle. 1987;7(6):333-7.
9. Lamontagne A, Malouin F, Richards CL. Contribution of passive stiffness to ankle plantarflexor moment during gait after stroke. Arch Phys Med Rehabil. 2000;81(3):351-8.
10. Lamontagne A, Malouin F, Richards CL. Locomotor specific measure of spasticity of plantarflexor muscles after stroke. Arch Phys Med Rehabil. 2001;82(12):1696-704.
11. Lin PY, Yang YR, Cheng SJ, Wang RY. The relation between ankle impairments and gait velocity and symmetry in people with stroke. Arch Phys Med Rehabil. 2006;87(4):562-8.
12. Goldspink G, Williams PE. Muscle fibre and connective tissue changes associated with use and disuse. In: Ada A, Canning C, editors. Foundation for practice. Topics in neurological physiotherapy. London: Heinemann; 1990. p 197-218.
13. Chung SG, Van Rey E, Bai Z, Roth EJ, Zhang LQ. Biomechanic changes in passive properties of hemiplegic ankles with spastic hypertonia. Arch Phys Med Rehabil. 2004;85(10):1638-46.
14. Detrembleur C, Renders A, Willemart T, van den Hecke A. Usefulness of gait analysis combined with motor point block in a stroke patient. Acta Neurol Belg. 2000;100:107-10.
15. Doderlein L. The surgical management of spastic foot deformities. Orthopade. 2004;33(10):1152-62.
16. Kerrigan DC, Glenn MB. An illustration of clinical gait laboratory use to improve rehabilitation management. Am J Phys Med Rehabil. 1994;73(6):421-7.
17. Goodman MJ, Menown JL, West JM, Barr KM, Vander Linden DW, McMulkin ML. Secondary gait compensations in individuals without neuromuscular involvement following a unilateral imposed equinus constraint. Gait Posture. 2004;20(3):238-44.
18. Hebela N, Keenan MA. Neuro-orthopedic management of the dysfunctional extremity in upper motor neuron syndromes. Eura Medicophys. 2004;40(2):145-56.
19. Deltombe Th, Gustin Th, De Cloedt Ph, Laloux P, De Wispelaere JF. La prise en charge interdisciplinaire du traitement de la spasticité. Louvain Médical. 2002;121:351-63.
20. Bohannon EW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206-7.
21. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the tone assessment scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil. 1999;80(9):1013-6.
22. Blackburn M, van Vliet P, Mockett SP. Reliability of measurements obtained with the modified Ashworth scale in the lower extremities of people with stroke. Phys Ther. 2002;82(1):25-34.
23. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticité. In: Held JP, Pierrot-Deseilligny E, editors. Rééducation motrice des affections neurologiques. Paris: JB Baillière et Fils; 1969. p. 31-42.
24. Haugh AB, Pandyan AD, Johnson GR. A systematic review of the Tardieu scale for the measurement of spasticity. Disabil Rehabil. 2006;28(15):899-907.
25. Glenn MB. Nerve blocks. In: Glenn M, Whyte J, editors. The practical management of spasticity in children and adults. Philadelphia: Lea & Febiger; 1990. p. 227-58.
26. Deltombe T, De Wispelaere JF, Gustin T, Jamart J, Hanson P. Selective blocks of the motor nerve branches to the soleus and tibialis posterior muscles in the management of the spastic equinovarus foot. Arch Phys Med Rehabil. 2004;85:54-58.
27. Sook Kim H, Hye Hwan J, Lee PK, Kwon JY, Yeon Oh-Park M, Moon Kim J, Ho Chun M. Localization of the motor nerve branches and motor points of the triceps surae muscles in Korean cadavers. Am J Phys Med Rehabil. 2002;81(10):765-9.
28. Filipetti P, Decq P. Interest of anesthetic blocks for assessment of the spastic patient. A series of 815 motor blocks. Neurochirurgie. 2003;49:226-38.
29. Buffenoir K, Decq P, Lefaucheur JP. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block nerve branches to the triceps surae muscle. Clin Neurophysiol. 2005;116(7):1596-600.
30. Deltombe T, Nisolle JF, De Cloedt P, Hanson P, Gustin T. Tibial nerve block with anesthetics resulting in Achilles tendon avulsion. Am J Phys Med Rehabil. 2004;83(4):331-4.
31. Parziale JR, Marino AR, Herndon JH. Diagnostic nerve block resulting in compartment syndrome. Case report. Am J Phys Med Rehabil. 1988;67(2):82-4.
32. Decq P, Cuny E, Filipetti P, Keravel Y. Role of soleus muscle in spastic equinus foot. Lancet. 1998;352(9122):118.
33. Arendzen JH, van Duijn H, Beckmann MK, Harlaar J, Vogelaar TW, Prevo AJ. Diagnostic nerve blocks of the tibial nerve in spastic hemiparesis: effects on clinical, electrophysiological and gait parameters. Scand J Rehabil Med. 1992;24:75-81.
34. Deltombe T, Detrembleur C, Hanson P, Gustin T. Selective tibial neurotomy in the treatment of spastic equinovarus foot: a 2-year follow-up of three cases. Am J Phys Med Rehabil. 2006;85(1):82-8.
35. Perry J. The use of gait analysis for surgical recommendations in traumatic brain injury. J Head Trauma Rehabil. 1999;14(2):116-35.
36. Caillet F, Mertens P, Rabaseda S, Boisson D. Three dimensional gait analysis and controlling spastic foot on stroke patients. Ann Readapt Med Phys. 2003;46(3):119-31.
37. Gok H, Kucukdeveci A, Altinkaynak H, Yavuzer G, Ergin S. Effects of ankle-foot orthosis on hemiparetic gait. Clin Rehabil. 2003;17(2):137-9.
38. Logigian MK, Samuels MA, Falconer J, Zagar R. Clinical exercise trial for stroke patients. Arch Phys Med Rehabil. 1983;64:364-7.
39. Lord JP, Hall K. Neuro-muscular reeducation versus traditional programs for stroke rehabilitation. Arch Phys Med Rehabil. 1986;67:88-91.
40. Moreland JD, Thomson MA, Fuoco AR. Electromyographic biofeedback to improve lower extremity function after stroke: a meta-analysis. Arch Phys Med Rehabil. 1998;79(2):134-40.
41. Selles RW, Li X, Lin F, Chung SG, Roth EJ, Zhang LQ. Feedback-controlled and programmed stretching of the ankle plantarflexors and dorsiflexors in stroke: effect of a 4-week intervention program. Arch Phys Med Rehabil. 2005;86(12):2330-6.
42. Yeh CY, Tsai KH, Chen JJ. Effects of prolonged muscle stretching with constant torque or constant angle on hypertonic calf muscles. Arch Phys Med Rehabil. 2005;86(2):235-41.
43. Yeh CY, Chen JJ, Tsai KH. Quantitative analysis of ankle hypertonia after prolonged stretch in subjects with stroke. J Neurosci Methods. 2004;137(2):305-14.
44. Glanz M, Klawansky S, Stason W, Berkey C, Chalmers TC. Functional electrostimulation in poststroke rehabilitation: a meta-analysis of the randomized controlled trials. Arch Phys Med Rehabil. 1996;77(6):549-53.
45. Yan T, Hui-Chan CW, Li LS. Functional electrical stimulation improves motor recovery of the lower extremity and walking ability of subjects with first acute stroke. Stroke. 2005;36(1):80-5.
46. Burridge JH, Taylor PN, Hagan SA, Wood DE, Swain ID. The effects of common peroneal stimulation on the effort and speed of walking: a randomized controlled trial with chronic hemiplegic patients. Clin Rehabil. 1997;11(3):201-10.
47. Taylor PN, Burridge JH, Dunkerley AL, Wood DE, Norton JA, Singleton C, Swain ID. Clinical use of the Odstock dropped foot stimulator: its effect on the speed and effort of walking. Arch Phys Med Rehabil. 1999;80(12):1577-83.
48. Granat MH, Maxwell DJ, Ferguson AC, Lees KR, Barbenel JC. Peroneal stimulator; evaluation for the correction of spastic drop foot in hemiplegia. Arch Phys Med Rehabil. 1996;77(1):19-24.
49. Taylor PN, Burridge JH, Dunkerley AL, Lamb A, Wood DE, Norton JA, Swain ID. Patient's perception of the Odstock Dropped Foot Stimulator (ODFS). Clin Rehabil. 1999;13(5):439-46.
50. Perry J, Montgomery J. Gait of the stroke patient and orthotic indications. In: Brandstater ME, Basmajian JV, editors. Stroke rehabilitation. Baltimore (MD): Williams & Wilkins; 1987. p. 246-83.
51. Hesse S, Luecke D, Jahnke MT, Mauritz KH. Gait function in spastic hemiparetic patients walking barefoot, with firm shoes, and with ankle-foot orthosis. Int J Rehabil Res. 1996;19(2):133-41.
52. Hesse S, Werner C, Matthias K, Stephen K, Berteanu M. Non-velocity-related effects of a rigid double-stopped ankle-foot orthosis on gait and lower limb muscle activity of hemiparetic subjects with an equinovarus deformity. Stroke. 1999;30(9):1855-61.
53. de Wit DC, Buurke JH, Nijlant JM, Ijzerman MJ, Hermens HJ. The effect of an ankle-foot orthosis on walking ability in chronic stroke patients: a randomized controlled trial. Clin Rehabil. 2004;18(5):550-7.
54. Pohl M, Mehrholz J. Immediate effects of an individually designed functional ankle foot orthosis on stance and gait in hemiparetic patients. Clin Rehabil. 2006;20:324-30.
55. Danielsson A, Sunnerhagen KS. Energy expenditure in stroke subjects walking with a carbon composite ankle foot orthosis. J Rehabil Med. 2004;36(4):165-8.
56. Iwata M, Kondo I, Sato Y, Satoh K, Soma M, Tsushima E. An ankle-foot orthosis with inhibitor bar: effect on hemiplegic gait. Arch Phys Med Rehabil. 2003;84(6):924-7.
57. Geboers JF, Drost MR, Spaans F, Kuipers H, Seelen HA. Immediate and long-term effects of ankle-foot orthosis on muscle activity during walking: a randomized study of patients with unilateral foot drop. Arch Phys Med Rehabil. 2002;83(2):240-5.
58. Grissom SP, Blanton S. Treatment of upper motoneuron plantarflexion contractures by using an adjustable ankle-foot orthosis. Arch Phys Med Rehabil. 2001;82(2):270-3.
59. Gracies JM, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity. Part II : General and regional treatments. Muscle Nerve. 1997;Suppl 6:S92-120.
60. Groves L, Shellenberger MK, Davis CS. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Adv Ther. 1998;15(4):241-51.
61. Tardieu C, Tardieu G, Hariga J, Gagnard L. Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on decerebrate cat. Dev Med Child Neurol. 1968;10:555-68.
62. Gracies JM, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity. Part I: local treatments. Muscle Nerve. 1997;Suppl 6:S61-91.
63. Garland DE, Lucie RS, Waters RL. Current uses of open phenol block for adult acquired spasticity. Clin Orthop Relat Res. 1982;165:217-22.
64. Moore TJ, Anderson RB. The use of open phenol blocks to the motor branches of the tibial nerve in adult acquired spasticity. Foot Ankle. 1991;11(4):219-21.
65. Kirazli Y, On AY, Kismali B, Aksit R. Comparison of phenol block and botulinum toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil. 1999;77(6):510-5.
66. Petrillo CR, Knoploch S. Phenol block of the tibial nerve for spasticity: a long-term follow-up study. Int Disabil Stud. 1988;10(3):97-100.
67. Jang SH, Ahn SH, Park SM, Kim SH, Lee KH, Lee ZI. Alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle to treat ankle spasticity in patients with hemiplegic stroke. Arch Phys Med Rehabil. 2004;85(3):506-8.
68. Chua KS, Kong KH. Clinical and functional outcome after alcohol neurolysis of the tibial nerve for anklefoot spasticity. Brain Inj. 2001;15(8):733-9.
69. Pelissier J, Viel E, Enjalbert M, Kotzki N, Eledjam JJ. Chemical neurolysis using alcohol (alcoholization) in the treatment of spasticity in the hemiplegic. Cah Anesthesiol. 1993;41(2):139-43.
70. Schroeder AS, Berweck S, Lee SH, Heinen F. Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques. Neurotox Res. 2006;9(2-3):189-96.
71. Davis EC, Barnes MP. Use of botulinum toxin in spasticity. In: Barnes MP, Johnson GR, editors. Upper motor neuron syndrome and spasticity: clinical management and neurophysiology. Cambridge (UK): Cambridge University Press; 2001. p. 206-22.
72. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Laqueny A. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry. 1996;61(3):265-9.
73. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Shorowetz A, Slowek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 2003;15(4):289-300.
74. Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci. 2005;26(1):26-31.
75. Rousseaux M, Compere S, Launay MJ, Kozlowski O. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles. J Neurol Sci. 2005;232(1-2):51-7.
76. Hesse S, Jahnke MT, Luecke D, Mauritz KH. Shortterm electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett. 1995;201(1):37-40.
77. Bayram S, Sivrioglu K, Karli N, Ozcan O. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study. Am J Phys Med Rehabil. 2006;85(1):75-81.
78. Johnson CA, Burridge JH, Strike PW, Wood DE, Swain ID. The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation. Arch Phys Med Rehabil. 2004;85(6):902-9.
79. Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil. 1998;79(5):532-5.
80. Cioni M, Esquenazi A, Hirai B. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot. Am J Phys Med Rehabil. 2006;85(7):600-6.
81. Hesse S, Lucke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, Mauritz KH. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry. 1994;57(11):1321-4.
82. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke. 1996;27(3):455-60.
83. Suputtitada A. Local botulinum toxin type A injections in the treatment of spastic toes. Am J Phys Med Rehabil. 2002;81(10):770-5.
84. Kishner S. Effects of phenol with botulinus toxin type A for the treatment of spasticity. Am J Phys Med Rehabil. 1999;78(5):500.
85. Bakheit AM, Fedorova NV, Skoromets AA, Timerbaeva SL, Bhakta BB, Coxon L. The beneficial antispasticity effect of botulinum type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry. 2004;75(11):1558-61.
86. Lorenz F. Uber chirurgishe behandlung der angeborenen spastischen gliedstarre. Wien Klin Rdsch. 1887;21:25-27.
87. Stoffel A. The treatment of spastic contractures. Am J Orthop Surg. 1912;10:611-644.
88. Gros C, Frerebeau P, Benezech J, Privat JM. Neurotomie radiculaire sélective. In: Simon L, editor. Actualités en réé ducation fonctionnelle. Paris: Masson; 1977. p. 230-5.
89. Feve A, Decq P, Filipetti P, Verroust J, Harf A, N'Guyen JP, Keravel Y. Physiological effects of selective tibial neurotomy on lower limb spasticity. J Neurol Neurosurg Psychiatry. 1997;63(5):575-8.
90. Roujeau T, Lefaucheur JP, Slavov V, Gherardi R, Decq P. Long-term course of the H-reflex after selective tibial neurotomy. J Neurol Neurosurg Psychiatr. 2003;74:913-7.
91. Sindou M, Mertens P. Selective neurotomy of the tibial nerve for treatment of the spastic foot. Neurosurgery. 1988; 23:738-44.
92. Decq P, Filipetti P, Cubillos A, Slavov V, Lefaucheur JP, Nguyen JP. Soleus neurotomy for treatment of the spastic equinus foot. Neurosurgery. 2000;47:1154-60.
93. Buffenoir K, Roujeau T, Lapierre F, Menei P, Menegalli-Boggelli D, Mertens P, Decq P. Spastic equinus foot: multicenter study of the long-term results of tibial neurotomy. Neurosurgery. 2004;55(5):1130-7.
94. Caillet F, Mertens P, Rabaseda S, Boisson D. The development of gait in the hemiplegic patient after selective tibial neurotomy. Neurochirurgie. 1998;44(3):183-91.
95. Collado H, Bensoussan L, Viton JM, Milhe De Bovis V, Delarque A. Does fascicular neurotomy have longlasting effects? J Rehabil Med. 2006;38(4):212-7.
96. Deltombe T, Decq P, Mertens P, Gustin T. Does fascicular neurotomy have long-lasting effects? A reply. J Rehabil Med. 2007;39(5):421-2.
97. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-92.
98. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet. 1985;2:125-7.
99. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS. Long term effects (more than 5 years) of intrathecal baclofen on impairment, disability and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry. 2004;75:1553-7.
100. Ben Smail D, Peskine A, Roche N, Mailhan L, Thiebaut I, Bussel B. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Mult Scler. 2006;12:101-3.
101. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg. 2003;98:291-5.
102. Cuny E. Intrathecal baclofen and traumatic brain injury. A review. Neurochirurgie. 2003;49:289-92.
103. Rémy-Néris O, Tiffreau V, Bouilland S, Bussel B. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehabil. 2003;84:643-50.
104. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke. 2001;32:2099-109.
105. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP. Intrathecal baclofen management of post stroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil. 2006;87(11):1509-15.
106. Francisco GE. Intrathecal baclofen therapy for stroke-related spasticity. Top Stroke Rehabil. 2001;8:36-46.
107. Francisco GE, Yablon SA, Schiess MC, Wiggs L, Cavalier S, Grissom S. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spasticity. Top Stroke Rehabil. 2006;13(4):74-85.
108. Emery E. Intrathecal baclofen. Literature review of the results and complications. Neurochirurgie. 2003;49:276-88.
109. Denormandie P, Kiefer C, Mailhan L, Even-Schneider A, Sorriaux G, Martin JN, Judet T. Surgical treatment of orthopedic deformities due to spasticity in the lower limb. Neurochirurgie. 2003;49:339-52.
110. Keenan MA, Lee GA, Tuckman AS, Esquenazi A. Improving calf muscle strength in patients with spastic equinovarus deformity by transfer of the long toe flexors to the os calcis. J Head Trauma Rehabil. 1999;14(2):163-75.
111. Pinzur MS, Sherman R, DiMonte-Levine P, Kett N, Trimble J. Adult-onset hemiplegia: changes in gait after muscle-balancing procedures to correct equines deformity. J Bone Joint Surg Am. 1986;68(8):1249-57.
112. Keenan MA, Creighton J, Garland DE, Moore T. Surgical correction of spastic equinovarus deformity in the adult head trauma patient. Foot Ankle. 1984;5(1):35-41.
113. Asencio G, Pelissier J, Privat JM, Bertin R, Megy B, Leonardi C. Surgery of the foot in equines deformity in hemiplegic adults. Rev Chir Orthop Reparatrice Appar Mot. 1993;79(1):41-8.
114. Edwards P, Hsu J. SPLATT combined with tendo Achilles lengthening for spastic equinovarus in adults: results and predictors of surgical outcome. Foot Ankle. 1993;14(6):335-8.
115. Vogt JC. Split anterior tibial transfer for spastic equinovarus foot deformity: retrospective study of 73 operated feet. J Foot Ankle Surg. 1998;37(1):2-7.
116. Curvale G, Rochwerger A, de Belenet H, Groulier P. Treatment of spastic equinovarus foot in the hemiplegic adult by retrograde fixation of the peroneus brevis tendon onto the anterior tibialis tendon. Rev Chir Orthop Reparatrice Appar Mot. 1999;85(3):286-92.
117. Morita S, Muneta T, Yamamoto H, Shinomiya K. Tendon transfer for equinovarus deformed foot caused by cerebrovascular disease. Clin Orthop Relat Res. 1998;350:166-73.